MX367732B - Tratamiento o prevencion de queratosis seborreica utilizando artemisinina y derivados de la misma. - Google Patents

Tratamiento o prevencion de queratosis seborreica utilizando artemisinina y derivados de la misma.

Info

Publication number
MX367732B
MX367732B MX2016013114A MX2016013114A MX367732B MX 367732 B MX367732 B MX 367732B MX 2016013114 A MX2016013114 A MX 2016013114A MX 2016013114 A MX2016013114 A MX 2016013114A MX 367732 B MX367732 B MX 367732B
Authority
MX
Mexico
Prior art keywords
artemisinin
keratosis
seboretic
prevention
derivatives
Prior art date
Application number
MX2016013114A
Other languages
English (en)
Other versions
MX2016013114A (es
Inventor
Sift Carter Rosemarie
Original Assignee
Epipharm Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epipharm Ag filed Critical Epipharm Ag
Publication of MX2016013114A publication Critical patent/MX2016013114A/es
Publication of MX367732B publication Critical patent/MX367732B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se relaciona con un método para tratar o prevenir la queratosis seborreica. El método comprende la aplicación local en un sujeto con necesidad de la misma artemisinina y/o uno o más compuestos relacionados estructuralmente. También se describen formulaciones tópicas que comprenden artemisinina y/o uno o más compuestos relacionados estructuralmente.
MX2016013114A 2014-04-28 2015-04-27 Tratamiento o prevencion de queratosis seborreica utilizando artemisinina y derivados de la misma. MX367732B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14166277 2014-04-28
PCT/EP2015/059104 WO2015165856A1 (en) 2014-04-28 2015-04-27 Treatment or prevention of seborrheic keratosis using artemisinin and derivatives thereof

Publications (2)

Publication Number Publication Date
MX2016013114A MX2016013114A (es) 2017-02-14
MX367732B true MX367732B (es) 2019-09-04

Family

ID=50624467

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016013114A MX367732B (es) 2014-04-28 2015-04-27 Tratamiento o prevencion de queratosis seborreica utilizando artemisinina y derivados de la misma.

Country Status (20)

Country Link
US (1) US9907782B2 (es)
EP (1) EP3137052B1 (es)
JP (1) JP6487459B2 (es)
KR (1) KR20160145818A (es)
CN (1) CN106456600B (es)
AU (1) AU2015252207B2 (es)
BR (1) BR112016024916A2 (es)
CA (1) CA2945646C (es)
DK (1) DK3137052T3 (es)
ES (1) ES2694623T3 (es)
HR (1) HRP20181981T1 (es)
IL (1) IL247909A0 (es)
MX (1) MX367732B (es)
PL (1) PL3137052T3 (es)
PT (1) PT3137052T (es)
RU (1) RU2702347C2 (es)
SG (1) SG11201607734PA (es)
SI (1) SI3137052T1 (es)
WO (1) WO2015165856A1 (es)
ZA (1) ZA201606837B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3824895A1 (en) * 2019-11-19 2021-05-26 Johnson & Johnson Consumer Inc. Compositions and methods for treating the eye
WO2024112391A1 (en) * 2022-11-23 2024-05-30 Timber Pharmaceuticals, Inc. Compositions for local delivery of drug actives
WO2025173801A1 (en) * 2024-02-14 2025-08-21 L'oreal Cosmetic process using microneedles

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2712861C2 (de) 1977-03-21 1986-02-27 Schering AG, 1000 Berlin und 4709 Bergkamen 17-Acetoxy-6-chlor-15β-hydroxy-1α,2α-methylen-4,6-pregnadien-3,20-dion, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
US4916204A (en) * 1987-07-31 1990-04-10 Massachusetts Institute Of Technology Pure polyanhydride from dicarboxylic acid and coupling agent
JPH03170422A (ja) 1989-11-22 1991-07-24 Dermatologic Res Corp 皮膚疾患の治療法
US7381427B2 (en) 2001-02-09 2008-06-03 Mickey Miller Seborrheic keratosis treatment
AU2004290983A1 (en) * 2003-11-19 2005-06-02 Vecta Ltd. Methods and compositions for the treatment of Helicobacter pylori-associated diseases using endoperoxide bridge-containing compounds
RU2423974C2 (ru) * 2005-10-20 2011-07-20 ЭПИФАРМ ГмбХ Лечение и профилактика доброкачественных пигментных пятен (невусов) с помощью артемизинина и его производных
US8193376B2 (en) * 2007-01-01 2012-06-05 Bioderm Research Artemisinin derivatives with natural amino acids, peptides, and amino sugars for the treatment of infection and topical condition in mammals
KR100795515B1 (ko) * 2007-01-11 2008-01-16 바이오스펙트럼 주식회사 아테미시닌을 포함하는 피부 미백용 조성물
WO2009033494A1 (en) * 2007-09-10 2009-03-19 Dafra Pharma N.V. 1- or 2-substituted artemisinin derivatives for increasing the in vivo biological activity of biologically active compounds
WO2012080466A2 (en) 2010-12-17 2012-06-21 Leo Pharma A/S Ingenols for treating seborrheic keratosis
KR20120085953A (ko) 2011-01-25 2012-08-02 원영두 피부미용제 및 그 제조방법
US9814659B2 (en) 2012-04-02 2017-11-14 Johnson & Johnson Consumer Inc. Methods of lightening the skin

Also Published As

Publication number Publication date
DK3137052T3 (da) 2019-01-02
CN106456600B (zh) 2020-08-04
HRP20181981T1 (hr) 2019-01-25
PL3137052T3 (pl) 2019-02-28
AU2015252207A1 (en) 2016-10-06
RU2016146373A (ru) 2018-05-28
IL247909A0 (en) 2016-11-30
PT3137052T (pt) 2018-11-30
CN106456600A (zh) 2017-02-22
US9907782B2 (en) 2018-03-06
US20170035727A1 (en) 2017-02-09
EP3137052A1 (en) 2017-03-08
MX2016013114A (es) 2017-02-14
SI3137052T1 (sl) 2019-01-31
CA2945646A1 (en) 2015-11-05
ZA201606837B (en) 2022-05-25
RU2702347C2 (ru) 2019-10-08
NZ724402A (en) 2020-11-27
EP3137052B1 (en) 2018-08-29
JP2017516761A (ja) 2017-06-22
ES2694623T3 (es) 2018-12-26
WO2015165856A1 (en) 2015-11-05
JP6487459B2 (ja) 2019-03-20
RU2016146373A3 (es) 2018-11-14
KR20160145818A (ko) 2016-12-20
SG11201607734PA (en) 2016-11-29
CA2945646C (en) 2020-12-15
AU2015252207B2 (en) 2019-09-12
BR112016024916A2 (pt) 2017-08-15

Similar Documents

Publication Publication Date Title
IL269354A (en) Compounds useful in the treatment or prevention of a prmt5-mediated disorder
MX2018006240A (es) Composiciones que comprenden cepas bacterianas.
HUE049591T2 (hu) Makrociklusos MCL-1 inhibitorok rák kezelésére
MX2016014253A (es) Inhibidores de desmetilasa-1 especifica de lisina.
IT201600104717A1 (it) Composizioni di tensioattivo per il trattamento di formazioni sotterranee e petrolio prodotto
CL2014001956A1 (es) Compuestos derivados de beta-lactamicos sustituidos con amidina; metodo para su preparacion; medicamento que los comprende; y su uso para el tratamiento y/o profilaxis de infecciones bacterianas.
PT3377516T (pt) Composição para o tratamento do cancro
EA201891251A1 (ru) Бициклические ингибиторы pad4
DK3119762T3 (da) Benzimidazol-derivater som erbb-tyrosin-kinase-inhibitorer til behandlingen af kræft
PL3145522T3 (pl) Kombinacja, kompozycja i sposób podawania kombinacji lub kompozycji zwierzętom
CL2018000596A1 (es) Nuevos compuestos bicíclicos como inhibidores de la atx
MX2015011281A (es) Composiciones de inh-c1 y metodos para la prevencion y el tratamiento de trastornos asociados con la deficiencia del inhibidor de c1 esterasa.
DK3524255T3 (da) Sammensætning til behandling af acne
CL2016000326A1 (es) Composiciones y método para tratar condiciones asociadas con el complemento
CL2016003074A1 (es) Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer.
IL268728A (en) Formulations of cannabinoids for the treatment of acne
PT3592355T (pt) Kx2-391/kx-01 para utilização no tratamento da queratose actínica
IL264589A (en) Combination therapy for the treatment of pancreatic cancer
LT3534885T (lt) Farneziltransferazės inhibitoriai, skirti naudoti vėžio gydymui
MX2017007000A (es) Composiciones que comprenden acido 15-hidroxieicosapentaenoico (15-hepe) y metodos para tratar o prevenir la fibrosis usando las mismas.
CL2016002151A1 (es) Derivados de piridazina para uso en la prevención o el tratamiento de un trastorno atáxico
UY36196A (es) Compuestos para usar en el tratamiento antihelmíntico
CY2024037I1 (el) Χρηση delgocitinib για την θεραπεια χρονιουεκζεματος χεριων
HRP20181816T1 (hr) Spojevi triaminopirimidina korisni za prevenciju ili liječenje malarije
MX367732B (es) Tratamiento o prevencion de queratosis seborreica utilizando artemisinina y derivados de la misma.

Legal Events

Date Code Title Description
FG Grant or registration